The medicines developer has completed a US$40 million private capital raising at 85 cents per share.
The post Why did…
NEW YORK, April 25, 2023 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines…
DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:
THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:
INSTRUMENT NAME …
Instrument ID [1838] (LWB - AU000000MSB8) suspended...…
Latest Ratings for MESO
DateFirmActionFromTo Aug 2021Chardan CapitalMaintainsSell Apr 2021Maxim GroupUpgradesHoldBuy Jan 2021JefferiesDowngradesBuyHold
View More…
ADRs End Higher, Mesoblast, Gol Linhas Aereas Inteligentes Trade Actively...…
Mesoblast ADSs Rally as FDA Accepts Remestemcel-L Resubmission >MESO...…
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
These ASX shares are having a strong session despite the market selloff.
The post Why Mesoblast, PolyNovo, Pushpay, and Weebit Nano…
Mesoblast has received some good news for the US FDA this morning.
The post Mesoblast share price rockets 23% on FDA…
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
These ASX shares are having a strong session on Tuesday...
The post Why De Grey, Kogan, Mayne Pharma, and Mesoblast shares…
Mesoblast (MSB) has reported results from a recent phase III trial showing…...…
NEW YORK, Feb. 27, 2023 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines…
Single Intra-Myocardial Intervention with Rexlemestrocel-L Reduced Cardiovascular Death, Myocardial Infarction or Stroke Over Mean Follow-Up of 30 Months in High-Risk Patients…
NEW YORK, Feb. 26, 2023 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines…
This healthcare share has started 2023 in sensational form and is now up 50% year to date...
The post Mesoblast share…
NEW YORK, Feb. 08, 2023 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines…
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Mesoblast Shares Rise 11% After Resubmitting Biologics License Application...…
These ASX shares are outperforming the market on Wednesday..
The post Why Argosy Minerals, Credit Corp, Flight Centre, and Mesoblast shares…
Validation of Remestemcel-L Potency Assay used in the Phase 3 Trial which Measures In-Vivo Activity based on Mechanism of Action...…
Mesoblast Operational and Financial Highlights for Quarter Ended December 31, 2022 Mesoblast Operational and Financial Highlights for Quarter Ended December…
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
These ASX shares are ending the week in the red...
The post Why Brainchip, Core Lithium, Deterra Royalties, and Mesoblast shares…